Federal Register / Vol. 86, No. 5 / Friday, January 8, 2021 / Notices 1519 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the Advisory Committee on 

Heritable Disorders in Newborns and 

Children 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In accordance with section 

1111(g) of the Public Health Service 

(PHS) Act, and the Federal Advisory 

Committee Act, this notice announces 

that the Advisory Committee on 

Heritable Disorders in Newborns and 

Children (ACHDNC or Committee) has 

scheduled a public meeting to be held 

on Thursday, February 11, 2021, and 

Friday, February 12, 2021. Information 

about the ACHDNC and the agenda for 

this meeting can be found on the 

ACHDNC website at https://

www.hrsa.gov/advisory-committees/ 

heritable-disorders/index.html. 

DATES: Thursday, February 11, 2021, 

10:00 a.m.–3:00 p.m. Eastern Time (ET), 

and Friday, February 12, 2021, 10:00 

a.m.–2:00 p.m. ET. 

ADDRESSES: This meeting will be held 

via webinar. While this meeting is open 

to the public, advance registration is 

required. Please visit the ACHDNC 

website for information on registration: 

https://www.hrsa.gov/advisorycommittees/heritable-disorders/ 

index.html. The deadline for registration 

is 12:00 p.m. ET on February 10, 2021. 

Instructions for accessing the meeting 

via webcast will be provided upon 

registration. 

FOR FURTHER INFORMATION CONTACT: 

Alaina Harris, Maternal and Child 

Health Bureau, HRSA, 5600 Fishers 

Lane, Room 18W66, Rockville, 

Maryland 20857; 301–443–0721; or 

ACHDNC@hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACHDNC 

provides advice and recommendations 

to the Secretary of HHS (Secretary) on 

the development of newborn screening 

activities, technologies, policies, 

guidelines, and programs for effectively 

reducing morbidity and mortality in 

newborns and children having, or at risk 

for, heritable disorders. The ACHDNC 

reviews and reports regularly on 

newborn and childhood screening 

practices, recommends improvements in 

the national newborn and childhood 

screening programs, and fulfills 

requirements stated in the authorizing 

legislation. In addition, ACHDNC’s 

recommendations regarding inclusion of 

additional conditions for screening, 

following adoption by the Secretary, are 

evidence-informed preventive health 

services provided for in the 

comprehensive guidelines supported by 

HRSA through the Recommended 

Uniform Screening Panel (RUSP) 

pursuant to section 2713 of the PHS Act 

(42 U.S.C. 300gg-13). Under this 

provision, non-grandfathered group 

health plans and health insurance 

issuers offering group or individual 

health insurance are required to provide 

insurance coverage without cost-sharing 

(a co-payment, co-insurance, or 

deductible) for preventive services for 

plan years (i.e., policy years) beginning 

on or after the date that is one year from 

the Secretary’s adoption of the 

condition for screening. 

During the February 11–12, 2021, 

meeting, ACHDNC will hear from 

experts in the fields of public health, 

medicine, heritable disorders, rare 

disorders, and newborn screening. 

Agenda items include the following: 

(1) A presentation on potential 

processes for reviewing conditions on 

the RUSP; 

(2) Potential revisions to the condition 

nomination form; 

(3) Continuity of operations planning 

(within the context of COVID–19); 

(4) Innovations in long-term follow-up 

for conditions identified through 

newborn screening; and, 

(5) Workgroup updates. 

The agenda for this meeting does not 

include any plans for recommending a 

condition for inclusion in the RUSP. 

Agenda items are subject to change as 

priorities dictate. Information about the 

ACHDNC, including a roster of members 

and past meeting summaries, are also 

available on the ACHDNC website. 

Members of the public also will have 

the opportunity to provide comments. 

Public participants may submit written 

statements in advance of the scheduled 

meeting. Oral comments will be taken in 

the order they are requested and may be 

limited as time allows. Requests to 

provide a written statement or make oral 

comments to the ACHDNC must be 

submitted via the registration website by 

Friday, February 5, 2021, at 12:00 p.m. 

ET. 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Alaina 

Harris at the address and phone number 

listed above at least 10 business days 

prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–00095 Filed 1–7–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; NIAAA Review 

Subcommittee Member Conflict 

Applications. 

Date: March 3, 2021. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700 B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Luis Espinoza, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2109, Bethesda, MD 20892, 

(301) 443–8599, espinozala@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards, National 

Institutes of Health, HHS) 

Dated: January 4, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–00087 Filed 1–7–21; 8:45 am] 

BILLING CODE 4140–01–P 


tkelley on DSKBCP9HB2PROD with NOTICES